INTRODUCTION
Resistance to cytotoxic compounds is a ubiquitous property of living cells. One of the most frequently employed strategies for resistance in eukaryotes and prokaryotes is active extrusion of these compounds from the cell, reducing the intracellular concentration to subtoxic levels [1] . Some members of the ATPbinding cassette (ABC) superfamily of membrane transporters are drug-translocating ATPases that pump drugs out of the cytosol, thus conferring drug resistance in both prokaryotes and eukaryotes. This family includes the human multidrug-resistance (' MDR ') P-glycoprotein, which confers resistance to anti-cancer drugs [2] . Bacterial homologues include the Lactococcus lactis multidrug transporter (' LmrA ') [3] and the Streptomyces peucetius doxorubicin transporter (' DrrAB ') [4] . Related transporters are found in a number of pathogenic fungi and parasitic protozoa, where they confer resistance to antimicrobial drugs [5, 6] . Generally, ABC transporters are comprised of two homologous halves, each containing two parts : a transmembrane domain, putatively arranged into 6 α-helices, and a nucleotide binding domain (NBD).
Our understanding of the molecular events involved in the transmembrane-protein-catalysed extrusion of cytotoxic compounds is still rudimentary. To a large extent, this reflects the difficulties in obtaining sufficient protein to perform detailed functional and structural studies on the transmembrane components of these drug transport systems. If the ATP-binding domain could be functionally separated from the membrane domain of the transporter, it might then be possible to overexpress the Abbreviations used : ArsAB, Escherichia coli arsenical pump ; Sb(III), antimonite (i.e. potassium antimonyl tartrate) ; ABC, ATP-binding cassette ; NBD, nucleotide binding domain. 1 To whom correspondence should be addressed (e-mail A.Walmsley!bio.gla.ac.uk).
conformational forms that differ in their ligand binding affinities, and that ATP favours one form and Sb(III) the other. Ternary complex formation is rate-limited by a slow transition between these conformational forms, leading to a lag in attaining maximal steady-state activity. Sb(III) enhances the steady-state ATPase activity by inducing rapid product release, allowing ArsA to adopt a conformation that can bind MgATP for the next catalytic cycle. In the presence of Sb(III), ArsA avoids the rate-limiting isomerization at the end of the ATPase reaction and ATP hydrolysis becomes rate-limiting for the reaction. The binding of Sb(III) probably results in more effective pumping of the substrates from the cell by enhancing the rate of efflux.
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ATPase for detailed mechanistic studies. Fortunately, Nature has already performed this separation. In prokaryotes, catalytic subunits are frequently encoded by separate genes from the transmembrane subunits. However, to date, the purified ATPase subunits have all been from nutrient uptake systems, such as the maltose transporter (' MalK ') and histidine transporter (' HisP ') ATPases [7, 8] , and not from drug efflux pumps. The Escherichia coli arsenical pump (ArsAB) is a prokaryotic pump that exhibits structural and functional similarity to Pglycoprotein [9] . They are both efflux pumps for multiple forms of toxic compounds, have two similar consensus NBDs, are substrate-dependent ATPases, have 12 membrane-spanning α-helices arranged into two groups of six, and their NBDs contain allosteric sites. As such, ArsAB is a useful model for the study of the molecular mechanism of resistance pumps.
ArsAB is encoded by the ars operon of the conjugative Rfactor R773 [10] . Efflux of trivalent arsenicals and antimonials out of the cell reduces the intracellular concentration of those metalloid oxyanions to subtoxic levels, producing resistance [11] . ArsB is the 45 kDa membrane sector of the pump ; a 12-helix protein that acts as the oxyanion-translocating sector of the pump. ArsA is the 63 kDa catalytic subunit that couples ATP hydrolysis to oxyanion-translocation. ArsA is normally bound to ArsB, but can be purified as a soluble ATPase in the absence of ArsB. ArsA is arranged into two homologous halves, the Nterminal (A1) (residues 1-282) and C-terminal (A2) (residues 321-583) domains, which are connected by a flexible 25-residue linker (residues 289-313) [9, 12] . Each domain has a consensus NBD. Site-directed mutagenesis of these sequences indicates that both NBDs are required for catalysis and resistance [13, 14] . On the basis of genetic studies, the A1 and A2 NBDs have been shown to interact during catalysis [15, 16] and exhibit strong positive co-operativity [17] . In a most important advance, the structure of ArsA has been determined to atomic resolution [18] . The structure of ArsA indicates that the A1 and A2 halves of ArsA are arranged into two domains, with the NBDs formed from residues contributed from both domains, and are located at the interface between them in close proximity to one another. The ArsA subunit also has an allosteric site for arsenite and antimonite [Sb(III)] that enhances ATPase activity [19] . An understanding of the mechanism of activation of ArsAB by arsenicals and antimonials may well be of fundamental importance, because other pumps belonging to the ABC superfamily have been shown to possess non-catalytic substrate binding sites. For example, P-glycoprotein has a separate drug-binding site that functions as an allosteric domain [20] . In addition, Pglycoprotein has steroid and flavonoid binding sites located within the NBD [21] . The role of these sites may be to modulate the pump activity, possibly switching the pump on or off in the presence of modulators. The above features of ArsA, coupled with the fact that it is highly amenable to transient-kinetic approaches, which have been applied in elucidating both the substrate- [22] and product- [23] binding steps of the ATPase mechanism of ArsA, make it an ideal candidate for studies aimed at understanding the fundamental mechanism of the ' motor ' part of an efflux pump.
In the present study, we have conducted stopped-flow fluorescence experiments on the ArsA ATPase to investigate the molecular basis of allosteric activation. We have previously shown [19, 20, 24, 25] that intrinsic tryptophan fluorescence can be used to investigate the interaction of ArsA with nucleotides, defining a kinetic model of the ATPase mechanism. In the present study, we have used transient kinetic experiments to define the role of Sb(III) in regulating the ATPase mechanism. In the absence of Sb(III), there is a slow conformational change in the enzyme that is rate-limiting for ATPase hydrolysis, but, in the presence of the allosteric activator Sb(III), the rate of this conformational change is increased 100-fold and hydrolysis becomes rate-limiting for catalysis.
MATERIALS AND METHODS

Purification of His 6 -tagged ArsA ATPase
ArsA W159H6 ArsA was purified as described previously [22] , quickly frozen, aliquoted and stored at k80 mC. The concentration of purified ArsA was determined by UV absorbance at 280 nm. The absorption coefficient for W159H6 ArsA was calculated to be 20 250 M −" : cm −" [24] .
ATPase assays
A continuous assay was used to monitor phosphate production by ArsA. Essentially, the absorbance change at 360 nm, associated with the phosphorolysis of 2-amino-6-mercapto-7-methylpurine by the P i generated by the ATPase activity, was monitored [22] . The phosphorolysis reaction was catalysed by purine nucleotide phosphorylase. The components of the assay were provided as part of an EnzCheck phosphate assay kit (Molecular Probes, Eugene, OR, U.S.A.) and used according to the manufacturer's recommendations. Assays were performed in a solution of 40 mM Tris\HCl (pH 7.5), 2 mM MgCl # and 0.2 mM sodium azide. The change in absorbance with time was measured in a Unicam (UV2) UV\Vis spectrometer (Thermo Spectronic, Cambridge, U.K.). Absorbance changes were converted into phosphate concentrations with ∆A $'! l 12 mM −" : cm −" .
Fluorescence measurements
Time-resolved fluorescence measurements were carried out in an Applied Photophysics SX.18MV stopped-flow instrument (Lethearhead, Surrey, U.K.), operated at 20 mC. For measurements of the change in tryptophan fluorescence, the samples were excited with light at 292.5 nm, selected with a monochromator, and the emission was monitored at wavelengths above 335 nm using a cut-off filter. Invariably, equal volumes of the reactants were mixed together in the stopped-flow instrument using two syringes of equal volume. The concentration of ArsA was 5 µM, unless otherwise noted, in a solution of 50 mM Mops\KOH (pH 7.5) and 0.25 mM EDTA. All concentrations are for the mixing chamber, unless stated otherwise, so that the concentrations in the syringe were twice those quoted for the mixing chamber. In order to set up the stopped-flow instrument, protein and protein-ligand complexes were mixed with buffer and the photo-multiplier tube voltage increased until a 4 V signal was achieved. Fluorescence changes were recorded as an increase or decrease in this 4 V signal (i.e. an increase in the signal from 4 to 4.1 V would correspond to a 2.5 % increase in fluorescence, and from 4 to 3.9 V a 2.5 % quench in fluorescence), which was backed-off to zero and changes above and below this zero baseline were recorded.
Data analysis
Stopped-flow traces were analysed by fitting to single [e.g. s l A:exp −kt ; where s represents the change in signal (i.e. volts or percentage fluorescence), t the time, A and k the amplitude and rate constant for the signal change respectively] or multiple exponential functions [e.g. s l A " : exp −k(")t jA # : exp −k(#)t jA $ : exp −k($)t , for a triple-exponential function] using the non-linear regression software with the Applied-Photophysics stopped-flow. Concentration-dependency data were analysed by non-linear regression fitting to hyperbolic functions using SIGMAPLOT 4.0 (RockWare, Golden, CO, U.S.A.). Kinetic simulations were set up using the Pro-K program (Applied-Photophysics), which uses the Marquardt-Levenberg algorithm for global optimization of the reaction parameters.
RESULTS AND DISCUSSION
MgATP binding to the ArsA-Sb(III) complex
Only a small decrease in protein fluorescence occurred upon the formation of the ArsA-Sb(III) complex, but the kinetics of the binding and turnover of MgATP by ArsA were dependent upon the metalloid concentration. Previously, we have found [22] that mixing ArsA with MgATP induces an apparently monophasic increase in the tryptophan fluorescence over 100 s, before the fluorescence decays back towards the baseline over 1000 s ( Figure 1A ). We attributed this transient increase in the tryptophan fluorescence to the formation of a pre-steady-state intermediate, probably the ArsA-MgADP : P i complex. In contrast, the present study revealed that, when ArsA was pre-mixed with Sb(III) and then mixed with MgATP, there was a relatively rapid decrease in fluorescence, over 100 s, below the baseline fluorescence for unliganded ArsA ( Figure 1B ). This indicates that the ArsA-MgATP and ArsA-MgATP-Sb(III) complexes must be distinct conformations, because, relative to ArsA, the protein fluorescence of the ArsA-MgATP complex is enhanced, whereas that of the ArsA-MgATP-Sb(III) complex is quenched.
The stopped-flow trace shown in Figure 1 (B) for the mixing of 5 µM ArsA\2 mM Sb(III) and 2 mM ATP\5 mM Mg# + was best fitted to a triple-exponential function, with rate constants of 11.7, 0.82 and 0.066 s −" , suggesting that there are three different conformations of the enzyme. However, when the Sb(III) concentration was held constant at 2 mM, the rate constant for each phase increased with the ATP concentration in a hyperbolic manner, with K d values of 199p51, 233p87 and 379p109 µM for the fast, intermediate and slow phases respectively ( Figure 2 ). The rate constants for the three phases also increased in a hyperbolic manner with the Sb(III) concentration, for a fixed ATP concentration of 2 mM, with K d values of 51p8, 119p27 and 402p145 µM for the fast, intermediate and slow phases respectively ( Figure 3 ).
Since the formation of the ArsA-MgATP-Sb(III) ternary complex is characterized by a triphasic stopped-flow fluorescence profile, with the rate of each phase dependent upon both the MgATP and Sb(III) concentrations, this behaviour is indicative of the formation of three distinct ArsA-MgATP-Sb(III) ternary complexes. All of these phases occur with faster rate constants than k cat (see below), indicating that none are attributable to the final few turnovers of MgATP at the end of the reaction. Originally, ArsA was thought to have only a single Sb(III) binding site [9, 25, 26] , but the determination of the structure of the ArsA-MgADP-Sb(III) complex has revealed that three Sb(III) molecules are bound to ArsA in the complex [17] . One Sb(III) is bound to His"%) (A1) and Ser%#! (A2), one to Cys""$ (A1) and Cys%## (A2), and one to Cys"(# (A1) and His%&$ (A2). This suggests a physical interpretation of the kinetic behaviour for the formation of the ArsA-MgATP-Sb(III) ternary complex ; each Sb(III) complex results from the addition of an Sb(III) molecule to ArsA as the high-, medium-and low-affinity sites are successively filled. These Sb(III) complexes might play differential roles in controlling the affinities and activities of the two NBDs of ArsA. Indeed, mutagenesis experiments point towards a differential role for these sites, because mutation of His"%) Ala and His%&$ Ala resulted in a 5-fold reduction in the affinity for metal-stimulated ATP hydrolysis [17] . In contrast, mutations of the cysteine ligands were significantly more severe, with the Cys""$ Ser and Cys"(# Ser proteins exhibiting a 20-fold increase in the concentration of Sb(III) required for half-maximal activation, whereas the Cys%## Ser protein exhibited a 200-fold increase [19] . The studies presented herein will provide the baseline kinetic mechanism for the future analysis of these mutants, which will provide an understanding of the individual roles of the three binding sites for Sb(III).
Mg 2 + binding to the ArsA-ATP-Sb(III) complex
More complex behaviour was observed when the ArsA was premixed with Sb(III) and ATP before initiating the reaction with Mg# + . There was a rapid decrease in fluorescence over 0.25 s, followed by a slow increase over 5 s and a very slow decay over 100 s ( Figure 4B ). It should be noted that, because the ATP will cause an inner-filter effect, only the end point of the reaction, or final fluorescence, is comparable with the end point of the experiments in which ArsA and Sb(III) were mixed with MgATP. Similarly, in the absence of Sb(III) we found that, when ArsA was mixed with MgATP, the resulting increase in tryptophan fluorescence (over 100 s) was monophasic ( Figure 1A ), but multiphasic when ArsA and ATP were mixed with Mg# + ( Figure  4A ), indicating that ATP binds to ArsA in the absence of Mg# + to stabilize an alternative conformation [22] . The stopped-flow trace shown in Figure 4 (B) for the mixing of 5 µM ArsA\2 mM Sb(III)\1 mM ATP with 5 mM Mg# + was best fitted to a triphasic exponential equation yielding values of 12.3, 0.61 and 0.17 s −" for the three phases respectively. The fast phase was only apparent with Sb(III) concentrations in excess of 50 µM ; a double exponential fit of the data being adequate at lower concentrations.
ATP concentration-dependency
The rate of the fast phase for the formation of ArsA-MgATPSb(III) complex from ArsA\ATP\Sb(III) and Mg# + increased in a hyperbolic manner with the ATP concentration, with a relatively low-affinity K d of 1.58p0.46 mM, whereas the rates of the intermediate and slow phases had little dependency upon ATP concentration ( Figure 5 ). Previously, in an analogous experiment in which the ArsA-ATP complex was mixed with Mg# + [22] , we determined the affinity of the ATP binding-site to be 178 µM. This suggests that an effect of Sb(III) is to decrease the nucleotide binding affinity of ArsA. Indeed, simple competition between the ATP and Sb(III) for binding to ArsA would tend to increase the apparent K d for ATP (e.g.
would have the effect of increasing the apparent K d for ATP to 5.7 mM. Since the measured K d for ATP in the presence of Sb(III) is lower than predicted for simple competition, we conclude that ArsA can bind both ATP and Sb(III) simultaneously, and that there is negative co-operativity between the binding sites for these ligands.
Sb(III) concentration-dependency
In contrast, the rates of both the fast and intermediate phases for the formation of ArsA-MgATP-Sb(III) complex from ArsA\ ATP\Sb(III) and Mg# + were clearly dependent upon the Sb(III) concentration ( Figures 6A and 6B respectively) . The rate constant for the fast phase increased in a hyperbolic manner, with a K d of 50p12 µM ( Figure 6A ), whereas the rate constant for the intermediate phase decreased in a hyperbolic manner, with a K d of 65p30 µM ( Figure 6B ).
The kinetics of ArsA-MgATP-Sb(III) complex formation from ArsA\ATP\Sb(III) and Mg# + can be interpreted in terms of the following simplified kinetic scheme (Scheme 1), in which ArsA alternates between forms with no affinity (e.g. ArsA"-MgATP) and affinity (e.g. ArsA#-MgATP) for Sb(III) [27, 28] . We propose that the ArsA"-ATP and ArsA#-ATP complexes are formed during the ArsA equilibration time with ATP and Sb(III) prior to mixing with Mg# + . The binding of Mg# + , which is sufficiently rapid not to be rate-limiting for ternary complex formation, is necessary to form the ArsA#-MgATP complex to which Sb(III) can bind productively. An alternative proposal would be that ArsA exists as an equilibrium mixture of ArsA" and ArsA#, with MgATP binding rapidly to these complexes to A reasonable interpretation of the stopped-flow traces is to attribute the fast phase to the formation of the ArsA-MgATPSb(III) ternary complex (e.g. from ArsA#-MgATP) and the intermediate phase to a conformational change between forms that have low, or no affinity (e.g. ArsA"-MgATP), and high affinity (e.g. ArsA#-MgATP) for Sb(III) respectively. Since neither Sb(III) alone, nor Sb(III) and ATP together, cause an appreciable quench of the fluorescence of ArsA, the decrease in fluorescence observed when ArsA was mixed with MgATP and Sb(III) must be attributable to the formation of the ArsAMgATP-Sb(III) ternary complex, presumably as Sb(III) binds to the initial population of ArsA#-MgATP (e.g. determined below to be 30 % of the ArsA). As expected, the rate of ternary complex formation increased with both the ATP and Sb(III) concentrations ( Figure 6A ), because this phase is governed by k $ and k −$ . Following initial ternary complex formation, there is a further Figure 6B ), supporting our proposal that ArsA alternates between conformations that differ in their affinities for Sb(III) [27, 28] . Consistent with this model, we have previously shown [19] that (1) ArsA alternates between two conformational forms, (2) ArsA can bind ATP in the absence of Mg# + , (3) the binding of Mg# + to ArsA is rapid, and (4) the formation of the productive ArsA-MgATP complex is not rate limited by the transition between the different conformational forms. Presumably, then, formation of the ArsA-MgATPSb(III) ternary complex is rate limited by a transition between different conformational forms of the ArsA-MgATP complex (e.g. by the ArsA"-MgATP to ArsA#-MgATP transition as depicted in Scheme 1). The present study indicated that the binding of Sb(III) to the ArsA#-MgATP complex is fast compared with the ArsA"-MgATP to ArsA#-MgATP conformational transition, and that formation of the ArsA-MgATPSb(III) ternary complex is rate limited by a slow transition between these conformers, which have low-affinity and highaffinity for Sb(III) respectively. To simplify the analysis of the data in Figure 6 (B), the ArsA"-MgATP complex is presumed to have no affinity for Sb(III). Accordingly, k "
and k obs is given by the following function :
where k # and k −# are the forward and reverse rate constants respectively, for the transition from a conformation of ArsA incapable of binding Sb(III) (e.g. ArsA"-MgATP) to one that can bind Sb(III) (e.g. ArsA#-MgATP), and K $ is the dissociation constant (e.g. K $ l k −$ \k $ ) for the ArsA$-MgATP-Sb(III) ternary complex. A fit of the data in Figure 6 
where K $ is the dissociation constant for the ArsA$-MgATP- In summary, the model can provide a reasonable interpretation of both the profile of the stopped-flow traces and kinetic behaviour [e.g. Sb(III) concentration-dependency] of the individual phases of each trace. When ArsA\ATP\Sb(III) is mixed with Mg# + , there is rapid formation of the ArsA-MgATP binary complex and establishment of the equilibrium between ArsA"-MgATP and ArsA#-MgATP. Phase 1 is attributable to the formation of the ArsA$-MgATP-Sb(III) ternary complex from the initial (e.g. 30 %) ArsA#-MgATP equilibrium population. Further ternary complex formation requires the interconversion of ArsA"-MgATP into ArsA#-MgATP, observed as phase 2, which occurs at a slower rate than ternary complex formation from ArsA#-MgATP, and is rate-limiting. If the ternary complex has as lower fluorescence than the MgATP binary complexes, then ternary complex formation would lead to a decrease in fluorescence. Alternatively, if the ArsA#-MgATP binary complex has greater fluorescence than the ArsA"-MgATP and ternary complexes, there would then be a transient increase in fluorescence as ArsA"-MgATP is converted into ArsA#-MgATP. As a further test of the validity of the model, we attempted to fit the stopped-flow fluorescence trace in Figure 4 (B) directly to Scheme 1. For this analysis, the rate constants k # and k −# , and the ArsA"-MgATP, ArsA#-MgATP and ATP (free) concentrations were fixed at 0.46 s −" , 1.08 s −" , 3.51 µM (e.g. 70 % of the ArsA), 1.49 µM (e.g. 30 % of the ArsA) and 995 µM respectively ; the rate constants k $ and k −$ were set initially to give a K d of 50 µM [because the phase 1 and 2 Sb(III) concentration data indicate that it lies between 50 and 65 µM], but allowed to vary in the fit. This simulation provided a reasonable fit to the early part of the time course, but not the slow decrease in fluorescence (phase 3). A better fit, as assessed by the residual variance and shown as a smooth curve through the data in Figure 4 
Sb(III) binding to ArsA-MgATP
Sb(III) rapidly reversed the enhancement in protein fluorescence induced by mixing ArsA with MgATP. A typical stopped-flow trace is shown in Figure 7 . ArsA (5 µM) was premixed for less than 2 min with 0.5 mM ATP and 5 mM Mg# + before mixing with 0.1 mM Sb(III) in a stopped-flow instrument. There was an apparently monophasic decrease in the tryptophan fluorescence, which occurred with a rate constant of 19 s −" , followed by a slight transient increase in fluorescence. A reasonable explanation of this behaviour would be that the Sb(III) caused dissociation of the ArsA-MgADP : P i complex, followed by the binding of residual MgATP to ArsA. The rate constant for the former process was determined as a function of the Sb(III) concentration and found to vary in a hyperbolic manner (Figure 8 ), increasing in value, with an apparent K d of 332p93 µM, to a maximal rate of 98.7 s −" . The minimal rate was too slow to be accurately determined from the intercept of the hyperbolic plot, but was less than 1 s −" , suggesting that binding of the activator Sb(III) increases the rate of dissociation of products from the enzyme by at least 100-fold.
To test whether the decrease in fluorescence induced by Sb(III) was, in fact, due to dissociation of the ArsA-MgADP : P i complex, the ability of excess EDTA to dissociate the complex was investigated. An excess of EDTA rapidly reversed the fluorescence enhancement of the ArsA-MgADP : P i complex, presumably by sequestering the Mg# + to cause dissociation of ADP, with a k dissociation l 3.9 s −" ( Figure 9 ). As expected, the EDTA signal was smaller than that obtained when ArsA and MgATP were mixed with Sb(III), because EDTA only reverses the increase in fluorescence that accompanies formation of the ArsA-MgADP : P i complex (e.g. returning the fluorescence to the base line set by ArsA and ATP) (compare Figure 9 with Figure 7 ). The EDTA-induced dissociation of ADP did not result in a slow transient decrease in fluorescence, which could be attributed to the release of P i . This behaviour is consistent with our previous proposal of an ordered release of products, with the release of ADP following the slow release of P i [19] . Since both Sb(III) and EDTA reverse the fluorescence enhancement of the ArsA-MgADP : P i complex, we conclude that the effect of Sb(III) is to accelerate the rate of dissociation of the complex.
It is of interest to note that the binding of Sb(III) to the ArsA-MgATP complex, and MgATP to the ArsA-Sb(III) complex, are rapid processes, consistent with the formation of the ArsA-MgATP-Sb(III) ternary complex by a rapid randomorder binding process. In contrast, ArsA, equilibrated with ATP, apparently adopts a conformation (e.g. ArsA-ATP) that can only bind Sb(III) after the addition of Mg# + . The binding of Mg# + , which is rapid, leads to formation of the ArsA-MgATP complex to which Sb(III) binds. Moreover, pre-equilibrating ArsA with ATP appears to establish an equilibrium between two conformational forms of ArsA-MgATP, ArsA"-MgATP and ArsA#-MgATP (see Scheme 1), which differ in their affinities for Sb(III). This behaviour parallels that for the formation of the ArsA-MgADP-Sb(III) ternary complex [23] , suggesting that the ArsA-ATP and ArsA-MgADP complexes might resemble one another. We have previously hypothesized that ArsA utilizes ATP hydrolysis to cycle it between states that have high and low affinity for Sb(III) (e.g. ArsA-MgATP and ArsA-MgADP respectively), allowing it to sequester Sb(III) from the medium and to deliver it to ArsB as it changes from the high-to lowaffinity conformational form [23] . In this manner, ArsA is capable of pumping Sb(III) into the translocation pathway of ArsB, thus facilitating trans-membrane movement of the Sb(III). The steady-state rate of ATP hydrolysis by ArsA [equilibrated with 1 mM Sb(III)] was determined from the linear rate of release of phosphate catalysed by 1 µM ArsA. During the course of each measurement, less than 10 % of the ATP underwent hydrolysis, indicating that the measurements were of true initial rates. The data were fitted to an equation for substrate inhibition, yielding values for V max , K m and K i of 1.55i10 − 2 p0.23i10 − 2 nmol : s − 1 , 132p34 µM and 945p371 µM respectively. Inset. The time course of phosphate production during the steady-state turnover of ATP by ArsA. ArsA (1 µM) was manually mixed with 250 µM ATP/1 mM Sb(III) and the release of phosphate was monitored spectrophotometrically as the change in absorbance at 360 nm associated with the phosphorolysis of 2-amino-6-mercapto-7-methylpurine by phosphate. After a lag in attaining maximal ATPase activity, over approx. 100 s, the rate of P i production increased linearly, indicating a steady-state rate of 9.1i10 − 3 nmol : s − 1 : nmol − 1 of ArsA.
ATP hydrolysis
Previously, we have shown [19] that there is a burst in phosphate production during ATP hydrolysis, indicating that a step subsequent to ATP hydrolysis was rate-limiting for the reaction. In fact, we found that the rate-limiting step was a slow conformational change in the protein that followed product release. Furthermore, the release of P i occurred at a much slower rate than hydrolysis. This would predict that, if the binding of Sb(III) accelerated the isomerization step, then there should be no P i burst in the presence of Sb(III). Alternatively, if Sb(III) only accelerated the rate of release of P i , with the protein still undergoing a slow conformational change, then a P i burst should still occur. To test this feature of the mechanism, a phosphate assay was used to monitor the time course for the hydrolysis of 0.25 mM MgATP by 1 µM ArsA. Under these conditions, there was a short lag in phosphate release of approx. 100 s, following which P i increased linearly over the 20 min assay period ( Figure  10 , inset). Since no P i burst was observed, this behaviour indicated that neither P i release nor any subsequent conformational change was rate-limiting for the ATPase reaction.
The rate of P i production determined for the linear portion of the reaction was plotted as a function of the ATP concentration ( Figure 10 ). The steady-state rate increased in a hyperbolic manner to a maximal level around 300 µM ATP, and thereafter was subject to substrate inhibition ( Figure 10) . Hence values for V max , K m and K i , the substrate inhibition constant, were determined from a fit of the data to the following equation for substrate inhibition :
This analysis yielded values for V max , K m and K i of 1.55i10 −# nmol : s −" : nmol −" of ArsA, 132 µM and 945 µM respectively. In comparison, we previously obtained values in the absence of Sb(III) for V max , K m and K i of 0.54i10 −# nmol : s −" : nmol −" of ArsA, 73 µM and 792 µM respectively [19] . These results indicate that Sb(III) activates ATPase activity approx. 3-fold, but decreases the apparent affinity for ATP approx. 2-fold. These results suggest that the reversal of fluorescence by either Sb(III) or EDTA is attributable to product dissociation. As expected, the rate of this process was independent of the EDTA concentration, but increased in a hyperbolic manner with the Sb(III) concentration, indicative of a negative interaction between Sb(III) and the nucleotide binding sites. As noted above, when ArsA was pre-equilibrated with Sb(III) and then mixed with MgATP, rapid product dissociation was not observed, presumably because ADP dissociation is rate limited by ATP hydrolysis. This view is consistent with the fact that, in the presence of Sb(III), there is no apparent burst in P i production during the hydrolysis of 0.25 mM MgATP. To explain this behaviour, we propose that there is a change in the rate-limiting step from a slow isomerization in the absence of Sb(III) to hydrolysis of ATP in the presence of Sb(III). Under these circumstances, k cat should reflect the rate constant for the hydrolysis step. Previously, we attributed the slow increase in fluorescence of ArsA induced by MgATP to formation of the ArsA-MgADP : P i complex [19] . This process occurred at a rate of 0.027 s −" (for 0.25 mM ATP), which is similar to the value obtained for k cat in the presence of Sb(III) (k cat l 0.0155 s −" ). These results support the supposition that ATP hydrolysis becomes rate-limiting in the presence of Sb(III). The lag in steady-state activity can be readily explained in terms of kinetic Scheme 1 if the state stabilized by Sb(III) has greater activity than the state stabilized by ATP (e.g. ArsA#\ArsA$ states have greater activity than ArsA"). The activity lag is then simply a consequence of the ArsA"-MgATP to ArsA#-MgATP re-equilibration time (e.g. 10-90 s). 
